#METABOLOMICS WORKBENCH gcharkoftaki_20181112_062002 DATATRACK_ID:1568 STUDY_ID:ST001093 ANALYSIS_ID:AN001779 PROJECT_ID:PR000731
VERSION             	1
CREATED_ON             	November 13, 2018, 1:12 pm
#PROJECT
PR:PROJECT_TITLE                 	Impact of genetic suppression (shRNA) of ALDH1A1 expression in human colon
PR:PROJECT_TITLE                 	cancer cell line (COLO320)
PR:PROJECT_TYPE                  	Untargeted metabolomics analyses
PR:PROJECT_SUMMARY               	Using a multi-omics approach, we have investigated the impact of genetic
PR:PROJECT_SUMMARY               	suppression (shRNA) of ALDH1A1 expression on transcriptomics, proteomics and
PR:PROJECT_SUMMARY               	untargeted metabolomics analyses in a human colon cancer cell line (COLO320).
PR:PROJECT_SUMMARY               	The present study (i) generates an integrative omic profile of scramble shRNA
PR:PROJECT_SUMMARY               	vs. ALDH1A1 shRNA COLO320 cells, and (ii) identifies possible alterations in
PR:PROJECT_SUMMARY               	biological pathways caused by suppression of ALDH1A1 expression.
PR:INSTITUTE                     	Yale School of Public Health
PR:DEPARTMENT                    	Environmental Health Sciences
PR:LAST_NAME                     	Vasiliou
PR:FIRST_NAME                    	Vasilis
PR:ADDRESS                       	60 College str, New Haven, CT, 06520, USA
PR:EMAIL                         	georgia.charkoftaki@yale.edu; vasilis.vasiliou@yale.edu
PR:PHONE                         	2037857028
PR:FUNDING_SOURCE                	NIH
#STUDY
ST:STUDY_TITLE                   	Impact of genetic suppression (shRNA) of ALDH1A1 expression in human colon
ST:STUDY_TITLE                   	cancer cell line (COLO320)
ST:STUDY_TYPE                    	Untargeted metabolomics
ST:STUDY_SUMMARY                 	Using a multi-omics approach, we have investigated the impact of genetic
ST:STUDY_SUMMARY                 	suppression (shRNA) of ALDH1A1 expression on transcriptomics, proteomics and
ST:STUDY_SUMMARY                 	untargeted metabolomics analyses in a human colon cancer cell line (COLO320).
ST:STUDY_SUMMARY                 	The present study (i) generates an integrative omic profile of scramble shRNA
ST:STUDY_SUMMARY                 	vs. ALDH1A1 shRNA COLO320 cells, and (ii) identifies possible alterations in
ST:STUDY_SUMMARY                 	biological pathways caused by suppression of ALDH1A1 expression.
ST:INSTITUTE                     	Yale
ST:LAST_NAME                     	Vasiliou
ST:FIRST_NAME                    	Vasilis
ST:ADDRESS                       	60 College str
ST:EMAIL                         	georgia.charkoftaki@yale.edu; vasilis.vasiliou@yale.edu
ST:PHONE                         	203.737.8094
ST:NUM_GROUPS                    	2
#SUBJECT
SU:SUBJECT_TYPE                  	Cultured cells
SU:SUBJECT_SPECIES               	Homo sapiens
SU:TAXONOMY_ID                   	9606
SU:GENOTYPE_STRAIN               	ALDH1A1
SU:CELL_PASSAGE_NUMBER           	5
SU:CELL_COUNTS                   	4 million
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Additional sample data
SUBJECT_SAMPLE_FACTORS           	-	X01222018_Colo320_20V_Lipid_POS_10	Group name:WT Colo320	Label=1
SUBJECT_SAMPLE_FACTORS           	-	X01222018_Colo320_20V_Lipid_POS_11	Group name:WT Colo320	Label=1
SUBJECT_SAMPLE_FACTORS           	-	X01222018_Colo320_20V_Lipid_POS_12	Group name:WT Colo320	Label=1
SUBJECT_SAMPLE_FACTORS           	-	X01222018_Colo320_20V_Lipid_POS_13	Group name:WT Colo320	Label=1
SUBJECT_SAMPLE_FACTORS           	-	X01222018_Colo320_20V_Lipid_POS_14	Group name:WT Colo320	Label=1
SUBJECT_SAMPLE_FACTORS           	-	X01222018_Colo320_20V_Lipid_POS_15	Group name:WT Colo320	Label=1
SUBJECT_SAMPLE_FACTORS           	-	X01222018_Colo320_20V_Lipid_POS_16	Group name:WT Colo320	Label=1
SUBJECT_SAMPLE_FACTORS           	-	X01222018_Colo320_20V_Lipid_POS_2	Group name:KO ALDH1A1	Label=2
SUBJECT_SAMPLE_FACTORS           	-	X01222018_Colo320_20V_Lipid_POS_3	Group name:KO ALDH1A1	Label=2
SUBJECT_SAMPLE_FACTORS           	-	X01222018_Colo320_20V_Lipid_POS_4	Group name:KO ALDH1A1	Label=2
SUBJECT_SAMPLE_FACTORS           	-	X01222018_Colo320_20V_Lipid_POS_5	Group name:KO ALDH1A1	Label=2
SUBJECT_SAMPLE_FACTORS           	-	X01222018_Colo320_20V_Lipid_POS_7	Group name:KO ALDH1A1	Label=2
SUBJECT_SAMPLE_FACTORS           	-	X01222018_Colo320_20V_Lipid_POS_8	Group name:KO ALDH1A1	Label=2
SUBJECT_SAMPLE_FACTORS           	-	X01222018_Colo320_20V_Lipid_POS_9	Group name:KO ALDH1A1	Label=2
SUBJECT_SAMPLE_FACTORS           	-	X01222018_Colo320_20V_Lipid_POS_QC_07	Group name:QC	Label=3
SUBJECT_SAMPLE_FACTORS           	-	X01222018_Colo320_20V_Lipid_POS_QC_08	Group name:QC	Label=3
SUBJECT_SAMPLE_FACTORS           	-	X01222018_Colo320_20V_Lipid_POS_QC_09	Group name:QC	Label=3
SUBJECT_SAMPLE_FACTORS           	-	X01222018_Colo320_20V_Lipid_POS_QC_10	Group name:QC	Label=3
SUBJECT_SAMPLE_FACTORS           	-	X01222018_Colo320_20V_Lipid_POS_QC_11	Group name:QC	Label=3
SUBJECT_SAMPLE_FACTORS           	-	X01222018_Colo320_20V_Lipid_POS_QC_12	Group name:QC	Label=3
SUBJECT_SAMPLE_FACTORS           	-	X01222018_Colo320_20V_Lipid_POS_QC_13	Group name:QC	Label=3
SUBJECT_SAMPLE_FACTORS           	-	X01222018_Colo320_20V_Lipid_POS_QC_14	Group name:QC	Label=3
SUBJECT_SAMPLE_FACTORS           	-	X01222018_Colo320_20V_Lipid_POS_QC_15	Group name:QC	Label=3
SUBJECT_SAMPLE_FACTORS           	-	X01222018_Colo320_20V_Lipid_POS_QC_16	Group name:QC	Label=3
#COLLECTION
CO:COLLECTION_SUMMARY            	the cell culture medium was removed from the culture dishes, and the cells were
CO:COLLECTION_SUMMARY            	rinsed three times with ice-cold DPBS. For quenching and metabolite extraction,
CO:COLLECTION_SUMMARY            	1 mL ice-cold methanol was added to the plate and the cells were immediately
CO:COLLECTION_SUMMARY            	removed from the culture dish by scraping. The cell suspension was collected
CO:COLLECTION_SUMMARY            	into 2 mL Protein Lobind Eppendorf tubes that were placed on ice. After cell
CO:COLLECTION_SUMMARY            	counting (ViaStain AOPI Staining Solution,cridine orange/propidium iodide
CO:COLLECTION_SUMMARY            	Nexcelom Bioscience, Lawrence, MA) using an automated cellometer (Cellometer K2,
CO:COLLECTION_SUMMARY            	Nexcelom Bioscience, Lawrence, MA), the cell number was adjusted to 4x106
CO:COLLECTION_SUMMARY            	cells/tube. The cells were lysed by the application of a freeze-thaw cycle
CO:COLLECTION_SUMMARY            	(freezing in liquid nitrogen for 5 min, thawing in warm water for 5 min),
CO:COLLECTION_SUMMARY            	followed by sonication for 2 min. This process was repeated three times. The
CO:COLLECTION_SUMMARY            	samples were then centrifuged at 15,000 rpm for 10 min at 4°C, and the
CO:COLLECTION_SUMMARY            	supernatant was transferred to 2 mL tubes and dried using a Speed Vac (SPD111V
CO:COLLECTION_SUMMARY            	Savant, Thermo Fisher Scientific). The samples were then reconstituted in
CO:COLLECTION_SUMMARY            	isopropanol:acetonitrile:water (2:1:1 %v/v) and 2.5 μL Splash® Lipidomix®
CO:COLLECTION_SUMMARY            	(Avanti Polar Lipids Inc.) was added to each sample as an internal standard
CO:SAMPLE_TYPE                   	Cultured cells
#TREATMENT
TR:TREATMENT_SUMMARY             	Cellular ALDH1A1 expression was suppressed using MISSION shRNA lentiviral
TR:TREATMENT_SUMMARY             	transduction particles containing validated ALDH1A1 shRNA in a pLKO plasmid
TR:TREATMENT_SUMMARY             	vector. Scramble control shRNA in pLKO plasmid vector was used to generate
TR:TREATMENT_SUMMARY             	control cells (Sigma-Aldrich, St. Louis, MO). The shRNA transfection was carried
TR:TREATMENT_SUMMARY             	out as described previously [1] and individual stable clones were selected using
TR:TREATMENT_SUMMARY             	puromycin (10 μg/mL). Western blot analysis was used to verify changes in
TR:TREATMENT_SUMMARY             	ALDH1A1 expression using methods described previously [2]. References [1] S.
TR:TREATMENT_SUMMARY             	Guo, H. Bai, C.M. Megyola, S. Halene, D.S. Krause, D.T. Scadden, J. Lu, Complex
TR:TREATMENT_SUMMARY             	oncogene dependence in microRNA-125a-induced myeloproliferative neoplasms, Proc
TR:TREATMENT_SUMMARY             	Natl Acad Sci U S A, 109 (2012) 16636-16641. [2] Y. Chen, D.C. Thompson, V.
TR:TREATMENT_SUMMARY             	Koppaka, J.V. Jester, V. Vasiliou, Ocular aldehyde dehydrogenases: protection
TR:TREATMENT_SUMMARY             	against ultraviolet damage and maintenance of transparency for vision, Prog
TR:TREATMENT_SUMMARY             	Retin Eye Res, 33 (2013) 28-39.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Briefly, the cell culture medium was removed from the culture dishes, and the
SP:SAMPLEPREP_SUMMARY            	cells were rinsed three times with ice-cold DPBS. For quenching and metabolite
SP:SAMPLEPREP_SUMMARY            	extraction, 1 mL ice-cold methanol was added to the plate and the cells were
SP:SAMPLEPREP_SUMMARY            	immediately removed from the culture dish by scraping. The cell suspension was
SP:SAMPLEPREP_SUMMARY            	collected into 2 mL Protein Lobind Eppendorf tubes that were placed on ice.
SP:SAMPLEPREP_SUMMARY            	After cell counting (ViaStain AOPI Staining Solution,cridine orange/propidium
SP:SAMPLEPREP_SUMMARY            	iodide Nexcelom Bioscience, Lawrence, MA) using an automated cellometer
SP:SAMPLEPREP_SUMMARY            	(Cellometer K2, Nexcelom Bioscience, Lawrence, MA), the cell number was adjusted
SP:SAMPLEPREP_SUMMARY            	to 4x106 cells/tube. The cells were lysed by the application of a freeze-thaw
SP:SAMPLEPREP_SUMMARY            	cycle (freezing in liquid nitrogen for 5 min, thawing in warm water for 5 min),
SP:SAMPLEPREP_SUMMARY            	followed by sonication for 2 min. This process was repeated three times. The
SP:SAMPLEPREP_SUMMARY            	samples were then centrifuged at 15,000 rpm for 10 min at 4°C, and the
SP:SAMPLEPREP_SUMMARY            	supernatant was transferred to 2 mL tubes and dried using a Speed Vac (SPD111V
SP:SAMPLEPREP_SUMMARY            	Savant, Thermo Fisher Scientific). The samples were then reconstituted in
SP:SAMPLEPREP_SUMMARY            	isopropanol:acetonitrile:water (2:1:1 %v/v) and 2.5 μL Splash® Lipidomix®
SP:SAMPLEPREP_SUMMARY            	(Avanti Polar Lipids Inc.) was added to each sample as an internal standard.
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_SUMMARY        	The mobile phase involved a gradient comprising varying amounts of solutions A
CH:CHROMATOGRAPHY_SUMMARY        	(10 mM ammonium formate in 60% v/v acetonitrile) and B (10 mM ammonium formate
CH:CHROMATOGRAPHY_SUMMARY        	in 95% isopropanol and 5% acetonitrile). The linear gradient elution was:
CH:CHROMATOGRAPHY_SUMMARY        	40–43% B (0–2 min), 43–50% B (over 0.1 min), 50–54% B (over 10 min),
CH:CHROMATOGRAPHY_SUMMARY        	54–70% B (over 0.1 min), 70–99% B (over 5.9 min), 99-40% B (over 0.1 min),
CH:CHROMATOGRAPHY_SUMMARY        	and 40% B (for 2 min), run at 300 μl/min in positive Electrospray Ionization
CH:CHROMATOGRAPHY_SUMMARY        	mode and the column temperature was maintained at 55 °C
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
CH:INSTRUMENT_NAME               	Waters
CH:COLUMN_NAME                   	Waters Acquity BEH C18 (100 x 2.1mm, 1.7um)
CH:FLOW_RATE                     	300 μl/min
CH:SOLVENT_A                     	10 mM ammonium formate in 60% v/v acetonitrile
CH:SOLVENT_B                     	10 mM ammonium formate in 95% isopropanol and 5% acetonitrile
CH:INJECTION_TEMPERATURE         	4
CH:INTERNAL_STANDARD             	SPLASH™ Lipidomix® Mass Spec Standard (Avanti Polar Lipids, Inc.)
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:MS_COMMENTS                   	-
MS:INSTRUMENT_NAME               	Waters Synapt G2 XS QTOF
MS:INSTRUMENT_TYPE               	QTOF
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	POSITIVE
MS:MS_RESULTS_FILE               	ST001093_AN001779_Results.txt	UNITS:abundance corresponding to m/z	Has m/z:Yes	Has RT:Yes	RT units:Seconds
#END